ClinicalTrials.govpublic full text
Oral Arsenic Trioxide for NPM1-mutated AML
npmc+ aml, npm1 mutation, acute myeloid leukemia, oral arsenic trioxide, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 887991
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.